机译:抑制盘状蛋白域受体1减少了胰腺导管腺癌中的胶原介导的肿瘤性
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
School of Pharmacy Jinan University Guangzhou China.;
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
Department of Pathology UT Southwestern Medical Center Dallas Texas.;
Department of Pathology UT MD Anderson Cancer Center Houston Texas.;
Department of Surgical Oncology UT MD Anderson Cancer Center Houston Texas.;
Department of Clinical Science UT Southwestern Medical Center Dallas Texas.;
School of Pharmacy Jinan University Guangzhou China.;
School of Pharmacy Jinan University Guangzhou China.;
Division of Surgical Oncology Department of Surgery and Hamon Center for Therapeutic Oncology;
机译:抑制盘状蛋白域受体1减少了胰腺导管腺癌中的胶原介导的肿瘤性
机译:胰腺导管腺癌细胞中诱导的PTF1a表达激活腺泡基因网络,降低致瘤性,并使细胞对吉西他滨治疗敏感
机译:抑制胶原蛋白受体盘基蛋白结构域受体1(DDR1)降低了肺癌骨转移中的细胞存活,归巢和定植。
机译:开发一种新型的可生物降解的纳米树纹平台,用于克服治疗胰腺导管腺癌(PDAC)的挑战
机译:确定盘状素域受体在胰腺导管腺癌发病机制中的作用
机译:盘状蛋白结构域受体1的抑制作用降低胰腺导管腺癌中胶原介导的致瘤性。
机译:抑制伊马替尼阻止甲状腺素结构域受体防止胰纤维化在实验慢性胰腺炎中证明